MultiTox Seminar & Symposium
VENUE: Suntec Singapore Convention & Exhibition Centre
DATE: 9 May 2015
Hosted by Aesthetic Marketing, doctors and aesthetic professionals were invited to the MultiTox Seminar & Symposium, which highlighted the launch of the MultiTox, a state-of-the-art cradle for the Botulinum syringe, which may help the attendees of the symposium to expand their professional practices and provide improved treatment results for their patients.
Headlining the seminar and symposium was Dr. Tsahi Vider, M.D., a renowned general surgeon as well as owner and CEO of O-R Clinics and founder of InjecTec. Developed and introduced by InjecTec, the MultiTox is a highly efficient cradle for multi-purpose injections, which addresses the need for accuracy, precise placement, and exact dosages required during Botulinum Toxin (Botox) procedures – which syringes today cannot achieve. Dr. Tsahi Vider shared his insights on how MultiTox can revolutionize the Botox treatment as it offers meticulous attention to comfort and safety, thus improving the patient's overall experience. Cost-effective and highly precise, the MultiTox decreases the risks of asymmetrical results and eliminates over-injection or spillage. The symposium came to a close with a comprehensive Q&A session between Dr. Tsahi Vider and the attendees of the event.